标题
PD−L1 immunostaining: what pathologists need to know
作者
关键词
-
出版物
Diagnostic Pathology
Volume 16, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2021-10-25
DOI
10.1186/s13000-021-01151-x
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Clinical efficacy and safety of anti-PD-1/PD-L1 inhibitors for the treatment of advanced or metastatic cancer: a systematic review and meta-analysis
- (2020) Leitao Sun et al. Scientific Reports
- Cytology cell blocks from malignant pleural effusion are good candidates for PD-L1 detection in advanced NSCLC compared with matched histology samples
- (2020) Yinying Zou et al. BMC CANCER
- Immune checkpoint signaling and cancer immunotherapy
- (2020) Xing He et al. CELL RESEARCH
- Systematic review: Soluble immunological biomarkers in advanced non-small-cell lung cancer (NSCLC)
- (2020) Finn Mildner et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Implementation of PD-L1 22C3 IHC pharmDxTM in Cell Block Preparations of Lung Cancer: Concordance with Surgical Resections and Technical Validation of CytoLyt® Prefixation
- (2020) Si Kei Lou et al. ACTA CYTOLOGICA
- Variation of PD-L1 expression in locally advanced cervical cancer following neoadjuvant chemotherapy
- (2020) Yun Liang et al. Diagnostic Pathology
- Comparison of three PD-L1 immunohistochemical assays in head and neck squamous cell carcinoma (HNSCC)
- (2020) Emma J. de Ruiter et al. MODERN PATHOLOGY
- Resistance to PD-1/PD-L1 blockade cancer immunotherapy: mechanisms, predictive factors, and future perspectives
- (2020) Jin-Yu Sun et al. Biomarker Research
- Immunohistochemical detection of PD-L1 among diverse human neoplasms in a reference laboratory: observations based upon 62,896 cases
- (2019) Dennis P. O’Malley et al. MODERN PATHOLOGY
- Variation of Programmed Death Ligand 1 Expression After Platinum-based Neoadjuvant Chemotherapy in Lung Cancer
- (2019) Lei Guo et al. JOURNAL OF IMMUNOTHERAPY
- Existing and Emerging Biomarkers for Immune Checkpoint Immunotherapy in Solid Tumors
- (2019) Sanjeevani Arora et al. ADVANCES IN THERAPY
- Immune checkpoint inhibitors of PD-L1 as cancer therapeutics
- (2019) Akintunde Akinleye et al. Journal of Hematology & Oncology
- Tumor neoantigens: from basic research to clinical applications
- (2019) Tao Jiang et al. Journal of Hematology & Oncology
- Comparison of continuous measures across diagnostic PD-L1 assays in non-small cell lung cancer using automated image analysis
- (2019) Moritz Widmaier et al. MODERN PATHOLOGY
- The role of PD-L1 expression as a predictive biomarker: an analysis of all US Food and Drug Administration (FDA) approvals of immune checkpoint inhibitors
- (2019) Andrew A. Davis et al. Journal for ImmunoTherapy of Cancer
- Structure and Optimization of Checkpoint Inhibitors
- (2019) Sarah L. Picardo et al. Cancers
- PD-L1 diagnostic tests: a systematic literature review of scoring algorithms and test-validation metrics
- (2018) Margarita Udall et al. Diagnostic Pathology
- Digital image analysis improves precision of PD-L1 scoring in cutaneous melanoma
- (2018) Viktor H Koelzer et al. HISTOPATHOLOGY
- Regulation and Function of the PD-L1 Checkpoint
- (2018) Chong Sun et al. IMMUNITY
- Fundamental Mechanisms of Immune Checkpoint Blockade Therapy
- (2018) Spencer C. Wei et al. Cancer Discovery
- PD-L1 Testing in Guiding Patient Selection for PD-1/PD-L1 Inhibitor Therapy in Lung Cancer
- (2017) Katerina Ancevski Hunter et al. Molecular Diagnosis & Therapy
- Comparison of Different Antibody Clones for Immunohistochemistry Detection of Programmed Cell Death Ligand 1 (PD-L1) on Non–Small Cell Lung Carcinoma
- (2017) Edwin R. Parra et al. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY
- What does PD-L1 positive or negative mean?
- (2016) Antoni Ribas et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Human Tumor Antigens and Cancer Immunotherapy
- (2015) Nathalie Vigneron Biomed Research International
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now